Akorn (AKRX +5%) trades higher after announcing that it purchased 3 off-patent branded injectables from Denmark's Lundbeck for an upfront payment of $45M and a milestone payment of $15M after 3 years. The firm's CEO says the products will add to its niche portfolio of hospital-based injectables.
Akorn (AKRX +5%) trades higher after announcing that it purchased 3 off-patent branded...
From other sites
at CNBC.com (Mar 4, 2015)
at CNBC.com (Jul 15, 2014)
at CNBC.com (Jun 23, 2014)
at CNBC.com (Jan 23, 2014)
at CNBC.com (Aug 27, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs